146 related articles for article (PubMed ID: 29086823)
1. Liquid chromatography tandem mass spectrometry method for the quantification of vandetanib in human plasma and rat liver microsomes matrices: metabolic stability investigation.
Amer SM; Kadi AA; Darwish HW; Attwa MW
Chem Cent J; 2017 May; 11(1):45. PubMed ID: 29086823
[TBL] [Abstract][Full Text] [Related]
2. LC-MS/MS method for the quantification of masitinib in RLMs matrix and rat urine: application to metabolic stability and excretion rate.
Amer SM; Kadi AA; Darwish HW; Attwa MW
Chem Cent J; 2017 Dec; 11(1):136. PubMed ID: 29274040
[TBL] [Abstract][Full Text] [Related]
3. Validated LC-MS/MS Method for the Quantification of Ponatinib in Plasma: Application to Metabolic Stability.
Kadi AA; Darwish HW; Attwa MW; Amer SM
PLoS One; 2016; 11(10):e0164967. PubMed ID: 27764191
[TBL] [Abstract][Full Text] [Related]
4. A reliable and stable method for the determination of foretinib in human plasma by LC-MS/MS: Application to metabolic stability investigation and excretion rate.
Attwa MW; Kadi AA; Darwish HW; Amer SM; Alrabiah H
Eur J Mass Spectrom (Chichester); 2018 Aug; 24(4):344-351. PubMed ID: 29629565
[TBL] [Abstract][Full Text] [Related]
5. Investigation of metabolic stability of the novel ALK inhibitor brigatinib by liquid chromatography tandem mass spectrometry.
Darwish HW; Kadi AA; Attwa MW; Almutairi HS
Clin Chim Acta; 2018 May; 480():180-185. PubMed ID: 29458050
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of an HPLC-MS/MS method for the determination of arginine-vasopressin receptor blocker conivaptan in human plasma and rat liver microsomes: application to a metabolic stability study.
Alrabiah H; Kadi AA; Attwa MW; Mostafa GAE
Chem Cent J; 2018 May; 12(1):47. PubMed ID: 29717376
[TBL] [Abstract][Full Text] [Related]
7. Validated LC-MS/MS assay for quantification of the newly approved tyrosine kinase inhibitor, dacomitinib, and application to investigating its metabolic stability.
Abdelhameed AS; Kadi AA; Attwa MW; AlRabiah H
PLoS One; 2019; 14(4):e0214598. PubMed ID: 30947315
[TBL] [Abstract][Full Text] [Related]
8. Investigation of metabolic degradation of new ALK inhibitor: Entrectinib by LC-MS/MS.
Attwa MW; Darwish HW; Alhazmi HA; Kadi AA
Clin Chim Acta; 2018 Oct; 485():298-304. PubMed ID: 30006284
[TBL] [Abstract][Full Text] [Related]
9. Assessment of In Silico and In Vitro Selpercatinib Metabolic Stability in Human Liver Microsomes Using a Validated LC-MS/MS Method.
Attwa MW; AlRabiah H; Mostafa GAE; Bakheit AH; Kadi AA
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985590
[TBL] [Abstract][Full Text] [Related]
10. Development of an LC-MS/MS Method for Quantification of Sapitinib in Human Liver Microsomes: In Silico and In Vitro Metabolic Stability Evaluation.
Attwa MW; AlRabiah H; Mostafa GAE; Kadi AA
Molecules; 2023 Mar; 28(5):. PubMed ID: 36903565
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of an HPLC-MS/MS method for the determination of filgotinib, a selective Janus kinase 1 inhibitor: Application to a metabolic stability study.
AlRabiah H; Kadi AA; Attwa MW; Mostafa GAE
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Oct; 1154():122195. PubMed ID: 32943176
[TBL] [Abstract][Full Text] [Related]
12. A highly efficient and sensitive LC-MS/MS method for the determination of afatinib in human plasma: application to a metabolic stability study.
Kadi AA; Abdelhameed AS; Darwish HW; Attwa MW; Al-Shakliah NS
Biomed Chromatogr; 2016 Aug; 30(8):1248-55. PubMed ID: 26683307
[TBL] [Abstract][Full Text] [Related]
13. A semi-automated LC-MS/MS method for the determination of LCI699, a steroid 11β-hydroxylase inhibitor, in human plasma.
Li W; Luo S; Rebello S; Flarakos J; Tse FL
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():182-93. PubMed ID: 24814004
[TBL] [Abstract][Full Text] [Related]
14. LC-MS/MS method for the quantification of the anti-cancer agent infigratinib: Application for estimation of metabolic stability in human liver microsomes.
Mostafa GAE; Kadi AA; AlMasoud N; Attwa MW; Al-Shakliah NS; AlRabiah H
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122806. PubMed ID: 34325312
[TBL] [Abstract][Full Text] [Related]
15. Fast and sensitive LC-MS/MS method for the simultaneous determination of lisinopril and hydrochlorothiazide in human plasma.
Shah JV; Shah PA; Shah PV; Sanyal M; Shrivastav PS
J Pharm Anal; 2017 Jun; 7(3):163-169. PubMed ID: 29404033
[TBL] [Abstract][Full Text] [Related]
16. LC-MS/MS method for the determination of clodronate in human plasma.
Hasan M; Schumacher G; Seekamp A; Taedken T; Siegmund W; Oswald S
J Pharm Biomed Anal; 2014 Nov; 100():341-347. PubMed ID: 25194348
[TBL] [Abstract][Full Text] [Related]
17. Estimation of zorifertinib metabolic stability in human liver microsomes using LC-MS/MS.
Attwa MW; Al-Shakliah NS; AlRabiah H; Kadi AA; Abdelhameed AS
J Pharm Biomed Anal; 2022 Mar; 211():114626. PubMed ID: 35123331
[TBL] [Abstract][Full Text] [Related]
18. Quantitative high-throughput determination of endogenous retinoids in human plasma using triple-stage liquid chromatography/tandem mass spectrometry.
Gundersen TE; Bastani NE; Blomhoff R
Rapid Commun Mass Spectrom; 2007; 21(7):1176-86. PubMed ID: 17330217
[TBL] [Abstract][Full Text] [Related]
19. Plasma pharmacokinetics and tissue distribution study of cajaninstilbene acid in rats by liquid chromatography with tandem mass spectrometry.
Hua X; Fu YJ; Zu YG; Wu N; Kong Y; Li J; Peng X; Efferth T
J Pharm Biomed Anal; 2010 Jun; 52(2):273-9. PubMed ID: 20116956
[TBL] [Abstract][Full Text] [Related]
20. Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC-MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity Studies.
Attwa MW; Kadi AA; Abdelhameed AS; Alhazmi HA
Drug Des Devel Ther; 2020; 14():783-793. PubMed ID: 32158196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
